Home ETF List About

ETF Holdings Breakdown of GILD

Stock NameGuild Esports Plc
TickerGILD(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB00BMWVF760
LEI213800IE96YMHXDJ7H92

GILD institutional holdings

The following institutional investment holdings of GILD have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-30 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 2,935,675USD 325,859,925
2025-09-30 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 2,935,675 0.1%USD 325,859,925 -1.4%
2025-09-30 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 2,935,675USD 325,859,925
2025-09-30 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 1,897,412USD 210,612,732
2025-09-30 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 1,897,412USD 210,612,732
2025-09-30 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 1,897,412USD 210,612,732
2025-09-30 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 1,897,412USD 210,612,732 -1.5%
2025-09-30 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 815,687USD 90,541,257 -1.5%
2025-09-29 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 439,735USD 49,522,956 0.5%
2025-09-30 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 331,108USD 36,752,988 -1.5%
2025-09-29 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 331,108USD 37,289,383
2025-09-30 IE00B53SZB19 (iShares NASDAQ 100 UCITS ETF USD (Acc)) 1,529,987 0.0%USD 169,828,557 -1.4%
2025-09-30 IE00BYVQ9F29 (iShares NASDAQ 100 UCITS ETF) 1,529,987USD 169,828,557
2025-09-30 IE00BYX2JD69 (iShares MSCI World SRI UCITS ETF) 677,457USD 75,197,727
2025-09-30 IE00BMZ17T93 (iShares MSCI World SRI UCITS ETF GBP Hedged (Dist) GBP) 677,457USD 75,197,727
2025-09-30 IE00BMZ17X30 (iShares MSCI World SRI UCITS ETF USD Hedged (Dist)) 677,457USD 75,197,727
2025-09-30 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 375,889USD 41,723,679
2025-09-30 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 375,889USD 41,723,679
2025-09-30 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 375,889USD 41,723,679
2025-09-30 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 304,581 200.0%USD 33,808,491 201.5%
2025-09-30 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 304,581USD 33,808,491
2025-09-30 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 133,800USD 14,851,800
2025-09-30 IE00BYVJRR92 (iShares MSCI USA SRI UCITS ETF USD (Acc)) 358,103USD 39,749,433
2025-09-30 IE00BZ173V67 (iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)) 358,103USD 39,749,433 -1.5%
2025-09-30 IE00BZ173T46 (iShares MSCI USA SRI UCITS ETF USD (Dist)) 358,103USD 39,749,433 -1.5%
2025-09-30 IE00BMWPV470 (iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)) 358,103USD 39,749,433 -1.5%
2025-09-30 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 197,600USD 18,666,894
2025-09-30 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 211,156USD 23,438,316 -1.5%
2025-09-30 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 211,156USD 23,438,316
2025-09-30 IE00BP3QZB59 (iShares Edge MSCI World Value Factor UCITS ETF) 184,728USD 20,504,808
2025-09-30 IE00BFYTYS33 (iShares Edge MSCI World Value Factor UCITS USD Dist) 184,728USD 20,504,808
2025-09-30 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 96,362USD 10,696,182 -1.5%
2025-09-30 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 96,362USD 10,696,182
2025-09-30 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 79,235USD 8,795,085
2025-09-30 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 79,235USD 8,795,085
2025-09-30 IE00B8FHGS14 (iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)) 148,198USD 16,449,978
2025-09-30 IE00BGPP8L80 (iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)) 148,198USD 16,449,978
2025-09-30 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 85,724USD 8,098,182
2025-09-30 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 588,228USD 65,293,308 -1.5%
2025-09-30 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 588,228USD 65,293,308
2025-09-30 IE00BP3QZ825 (iShares Edge MSCI World Momentum Factor UCITS ETF) 225,127USD 24,989,097 -1.5%
2025-09-30 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 52,733 0.8%USD 5,853,363 -0.7%
2025-09-30 IE00B6SPMN59 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc)) 58,891USD 6,536,901
2025-09-30 IE00BD93YH54 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist)) 58,891 0.1%USD 6,536,901 -1.3%
2025-09-30 IE00B57X3V84 (iShares Dow Jones Global Sustainability Screened UCITS ETF USD (Acc)) 106,140USD 11,781,540
2025-09-29 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 26,692USD 3,006,053 0.5%
2025-09-30 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 136,629USD 15,165,819
2025-09-30 IE00BKVL7778 (iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)) 91,601USD 10,167,711
2025-09-30 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 133,224USD 14,787,864
2025-09-30 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 133,224USD 14,787,864
2025-09-30 IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)) 33,962USD 3,769,782 -1.5%
2025-09-30 IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist) 33,962USD 3,769,782
2025-09-30 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 29,828USD 2,459,356
2025-09-30 IE00BZ0PKT83 (iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) GBP) 33,683USD 3,738,813
2025-09-30 IE00BYXPXK00 (iShares STOXX World Equity Multifactor UCITS ETF EUR Hedged (Acc)) 33,683USD 3,738,813 -1.5%
2025-09-30 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 417,590USD 46,352,490
2025-09-30 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 417,590 0.6%USD 46,352,490 -0.9%
2025-09-30 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 23,770USD 2,638,470
2025-09-30 IE00BD1F4N50 (iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Acc) GBP) 78,134USD 8,672,874
2025-09-30 IE00BFF5RZ82 (iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)) 78,134USD 8,672,874
2025-09-30 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 2,737USD 303,807
2025-09-30 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 2,737USD 303,807
2025-09-30 IE00BKVL7331 (iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)) 22,280USD 2,473,080
2025-09-30 IE000OKVTDF7 (iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)) 25,612USD 2,842,932 -1.5%
2025-09-30 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 7,796USD 642,790 -1.8%
2025-09-30 IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF) 4,994USD 554,334
2025-09-30 IE00013A2XD6 (iShares MSCI ACWI SRI UCITS ETF USD(Dist)) 7,039USD 781,329
2025-09-30 IE00BZ0PKS76 (iShares STOXX USA Equity Multifactor UCITS ETF USD (Acc)) 3,033USD 336,663
2025-09-30 IE00BG13YZ23 (iShares Edge MSCI USA Multifactor UCITS ETF USD (Dist)) 3,033USD 336,663
2025-09-30 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 6,675USD 740,925
2025-09-30 IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc) 2,893USD 321,123 -1.5%
2025-09-30 IE000WHL2ZK1 (iShares U.S. Equity High Income UCITS ETF USD Inc) 1,215USD 134,865
2025-09-30 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 15,009USD 1,665,999
2025-09-30 IE0009VWHAE6 (iShares US Equity Enhanced Active UCITS ETF USD (Acc)) 44,098USD 4,894,878
2025-09-30 IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist)) 200USD 22,200
2025-09-30 IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc)) 200USD 22,200 -1.5%
2025-09-30 IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist)) 185USD 20,535 -1.5%
2025-09-30 IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc)) 185USD 20,535
Total =31,962,244 USD 3,543,343,085
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with GILD

Gilead Sciences, Inc. (NASDAQ:GILD) Receives $115.39 Average Target Price from Brokerages
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty-eight analysts that are currently covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the […] - 2025-09-19 02:43:07
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price hoisted by stock analysts at JPMorgan Chase & Co. from $135.00 to $145.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price target would indicate a potential […] - 2025-09-18 02:24:44
QQQM, GOOGL, ADBE, GILD: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco NASDAQ 100 ETF (Symbol: QQQM) where we have detected an approximate $350.8 million dollar inflow -- that's a 0.6% increase week over week in - 2025-09-16 11:51:08
SPYV, PFE, GILD, DHR: ETF Inflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Portfolio S&P 500 Value ETF (Symbol: SPYV) where we have detected an approximate $205.2 million dollar inflow -- that's a 0.7% increase week - 2025-09-05 11:52:16
Noteworthy ETF Inflows: SPHQ, CRM, GILD, ADP
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Quality ETF (Symbol: SPHQ) where we have detected an approximate $234.3 million dollar inflow -- that's a 1.6% increase week over - 2025-08-28 11:56:15
Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by Daiwa America
Daiwa America upgraded shares of Gilead Sciences (NASDAQ:GILD – Free Report) from a hold rating to a strong-buy rating in a research note issued to investors on Tuesday,Zacks.com reports. Several other research firms also recently weighed in on GILD. UBS Group increased their target price on Gilead Sciences from $108.00 to $112.00 and gave the […] - 2025-08-22 03:08:53
Insider Selling: Gilead Sciences (NASDAQ:GILD) Insider Sells $3,318,840.00 in Stock
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) insider Johanna Mercier sold 28,000 shares of Gilead Sciences stock in a transaction on Friday, August 15th. The shares were sold at an average price of $118.53, for a total transaction of $3,318,840.00. Following the completion of the transaction, the insider directly owned 114,168 shares of the […] - 2025-08-21 05:19:08
Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by Daiwa Capital Markets
Daiwa Capital Markets upgraded shares of Gilead Sciences (NASDAQ:GILD – Free Report) from a neutral rating to an outperform rating in a report published on Tuesday, Marketbeat Ratings reports. They currently have $128.00 price objective on the biopharmaceutical company’s stock. A number of other equities analysts have also commented on GILD. Morgan Stanley boosted their […] - 2025-08-20 03:12:44
Why Gilead Sciences is a Top 25 Dividend Giant (GILD)
Gilead Sciences Inc (Symbol: GILD) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $27.06B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 2.63% yield, according to the most recent Dividend Channel ''Div - 2025-08-14 08:40:15
QQQI, QCOM, GILD, AMAT: ETF Inflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Neos Nasdaq-100 High Income ETF (Symbol: QQQI) where we have detected an approximate $258.1 million dollar inflow -- that's a 7.5% increase week over - 2025-08-12 11:55:41
Company News for Aug 11, 2025
Companies In The News Are: GILD, TTD, TXRH, GEN. - 2025-08-11 05:15:00
UBS Group Boosts Gilead Sciences (NASDAQ:GILD) Price Target to $112.00
Gilead Sciences (NASDAQ:GILD – Free Report) had its target price upped by UBS Group from $108.00 to $112.00 in a research note issued to investors on Friday morning,Benzinga reports. UBS Group currently has a neutral rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently commented on the stock. Needham & Company […] - 2025-08-11 02:48:59
After-Hours Earnings Report for August 7, 2025 : GILD, MSI, EOG, MNST, FLUT, WPM, XYZ, TTWO, TTD, ED, MCHP, SLF
The following companies are expected to report earnings after hours on 08/07/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Gilead Sciences, Inc. (GILD)is reporting for the quarter ending June 30, 2025. The biomedical (gene) company's consensus e - 2025-08-07 15:00:01
IVE, COF, GILD, DHR: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Value ETF (Symbol: IVE) where we have detected an approximate $109.4 million dollar outflow -- that's a 0.3% decrease week over - 2025-07-23 11:50:17
Private Advisor Group LLC Has $4.29 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Private Advisor Group LLC raised its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 10.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 38,275 shares of the biopharmaceutical company’s stock after purchasing an additional 3,593 shares during the quarter. […] - 2025-07-23 07:50:52
Investors Purchase Large Volume of Call Options on Gilead Sciences (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the target of some unusual options trading activity on Monday. Traders purchased 25,184 call options on the company. This represents an increase of 49% compared to the average volume of 16,897 call options. Gilead Sciences Price Performance Shares of GILD stock opened at $109.06 on Wednesday. […] - 2025-07-16 02:54:43
MTUM, BSX, ISRG, GILD: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI USA Momentum Factor ETF (Symbol: MTUM) where we have detected an approximate $107.6 million dollar outflow -- that's a 0.6% decrease we - 2025-07-15 11:51:53
Flagship Harbor Advisors LLC Acquires 193 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Flagship Harbor Advisors LLC lifted its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.6% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,396 shares of the biopharmaceutical company’s stock after buying an additional 193 shares during the quarter. Flagship Harbor Advisors LLC’s holdings […] - 2025-06-26 05:07:01
Noteworthy ETF Outflows: TQQQ, AMGN, AMAT, GILD
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $179.6 million dollar outflow -- that's a 0.7% decrease week over week ( - 2025-06-25 11:51:51
Nilsine Partners LLC Purchases New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)
Nilsine Partners LLC purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 1,856 shares of the biopharmaceutical company’s stock, valued at approximately $208,000. Other institutional investors have also added to or reduced […] - 2025-06-23 05:30:56
Buy, Sell, Or Hold GILD Stock?
Despite a recent setback involving an FDA clinical hold on its HIV treatment trials (GS-1720 and GS-4182) due to declines in CD4+ T-cell counts, Gilead Sciences (NASDAQ:GILD) has posted a strong year-to-date performance, with its stock rising 18% compared to the S&P 500’s mod - 2025-06-23 01:05:18
Gilead Sciences, Inc. (NASDAQ:GILD) Holdings Boosted by Blue Trust Inc.
Blue Trust Inc. boosted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 13.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,998 shares of the biopharmaceutical company’s stock after purchasing an additional 472 shares during the period. Blue […] - 2025-06-22 05:24:57
Robertson Stephens Wealth Management LLC Has $383,000 Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Robertson Stephens Wealth Management LLC decreased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.9% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,420 shares of the biopharmaceutical company’s stock after selling 292 shares during the period. Robertson Stephens Wealth Management […] - 2025-06-20 05:41:11
Sowell Financial Services LLC Buys Shares of 8,142 Gilead Sciences, Inc. (NASDAQ:GILD)
Sowell Financial Services LLC bought a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 8,142 shares of the biopharmaceutical company’s stock, valued at approximately $912,000. A number of other institutional […] - 2025-06-19 05:20:55
Noteworthy ETF Outflows: TQQQ, AMGN, GILD, CMCSA
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $549.5 million dollar outflow -- that's a 2.1% decrease week over week ( - 2025-06-17 11:50:30
Gilead Sciences a Top Socially Responsible Dividend Stock With 2.9% Yield (GILD)
Gilead Sciences Inc (Symbol: GILD) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 2.9% yield, as well as being recognized by prominent asset managers as being a so - 2025-06-02 08:32:20
Insider Selling: Gilead Sciences, Inc. (NASDAQ:GILD) Insider Sells $3,010,560.00 in Stock
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) insider Johanna Mercier sold 28,000 shares of the firm’s stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $107.52, for a total transaction of $3,010,560.00. Following the completion of the transaction, the insider now directly owns 121,152 shares of […] - 2025-05-26 05:16:52
Stock Traders Purchase High Volume of Gilead Sciences Call Options (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Stock traders bought 22,722 call options on the stock. This is an increase of 50% compared to the typical daily volume of 15,175 call options. Gilead Sciences Stock Down 1.3% Shares of NASDAQ GILD opened at […] - 2025-05-22 02:51:15
XLV, SYK, PFE, GILD: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $282.9 million dollar outflow -- that's a 0.8% decrease - 2025-05-21 11:54:05
Sen. John Boozman Sells Gilead Sciences, Inc. (NASDAQ:GILD) Stock
Senator John Boozman (R-Arkansas) recently sold shares of Gilead Sciences, Inc. (NASDAQ:GILD). In a filing disclosed on May 14th, the Senator disclosed that they had sold between $1,001 and $15,000 in Gilead Sciences stock on April 16th. Senator John Boozman also recently made the following trade(s): Sold $1,001 – $15,000 in shares of Salesforce (NYSE:CRM) […] - 2025-05-15 03:06:44

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.